Author:
OIZUMI Kiyoshi,KOIKE Hiroyuki,SADA Toshio,MIYAMOTO Masaaki,NISHINO Hiroshi,MATSUSHITA Youichi,IIJIMA Yasuteru,YANAGISAWA Hiroaki
Reference14 articles.
1. Design of specific inhibitors of angiotensin converting enzyme: a new class of orally active antihypertensive agents;Ondetti;Science,1977
2. Effect of N-[(S)-1 carboxy-3 phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor response in vivo;Gross;J. Pharmacol. Exp. Ther.,1981
3. Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl] - L-alanyl]- (1S,3S,5S) - 2 - aza-bicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498);Becker;Arzneimittelforschung,1984
4. Biological properties of the angiotensin-converting enzyme inhibitor Cilazapril;Natoff;J. Cardiovasc. Pharmacol.,1985
5. The present molecules of converting enzyme inhibitors;Brunner;J. Cardiovasc. Pharmacol.,1985
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献